Compile Data Set for Download or QSAR
Report error Found 48 Enz. Inhib. hit(s) with all data for entry = 6170
TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM15581(US8633208, Clorgyline | [3-(2,4-dichlorophenoxy)pr...)
Affinity DataIC50: 27nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113080(US8633208, 23)
Affinity DataIC50: 150nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113058(US8633208, 1)
Affinity DataIC50: 220nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113077(US8633208, 20)
Affinity DataIC50: 250nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113081(US8633208, 24)
Affinity DataIC50: 280nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113071(US8633208, 14)
Affinity DataIC50: 350nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113082(US8633208, 25)
Affinity DataIC50: 450nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM15579(US8633208, Deprenyl | CHEMBL972 | L-Deprenyl | SLG...)
Affinity DataIC50: 480nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113075(US8633208, 18)
Affinity DataIC50: 670nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM50019848(CHEMBL10316 | Idazoxan | US8633208, Idazoxan | 4,5...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM50019848(CHEMBL10316 | Idazoxan | US8633208, Idazoxan | 4,5...)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113074(US8633208, 17)
Affinity DataIC50: 1.13E+3nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113079(US8633208, 22)
Affinity DataIC50: 1.49E+3nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113061(US8633208, 4)
Affinity DataIC50: 2.06E+3nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113079(US8633208, 22)
Affinity DataIC50: 2.09E+3nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113070(US8633208, 13)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113066(US8633208, 9)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113064(US8633208, 7)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113063(US8633208, 6)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113074(US8633208, 17)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113073(US8633208, 16)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113072(US8633208, 15)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113071(US8633208, 14)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113078(US8633208, 21)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113077(US8633208, 20)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113076(US8633208, 19)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113075(US8633208, 18)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113082(US8633208, 25)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113081(US8633208, 24)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113080(US8633208, 23)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113062(US8633208, 5)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113059(US8633208, 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113070(US8633208, 13)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113066(US8633208, 9)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113064(US8633208, 7)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113063(US8633208, 6)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113073(US8633208, 16)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113072(US8633208, 15)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113078(US8633208, 21)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM113076(US8633208, 19)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113062(US8633208, 5)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113061(US8633208, 4)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113059(US8633208, 2)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM113058(US8633208, 1)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM15581(US8633208, Clorgyline | [3-(2,4-dichlorophenoxy)pr...)
Affinity DataIC50: 1.43E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM15579(US8633208, Deprenyl | CHEMBL972 | L-Deprenyl | SLG...)
Affinity DataIC50: 1.91E+4nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] B(Human)
Rottapharm

US Patent
LigandPNGBDBM85213(CHEMBL58343 | US8633208, Agmatine | NSC_199 | CAS_...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent

TargetAmine oxidase [flavin-containing] A(Human)
Rottapharm

US Patent
LigandPNGBDBM85213(CHEMBL58343 | US8633208, Agmatine | NSC_199 | CAS_...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibitory activity of compounds was evaluated by a homogeneous luminescent method, the MAO-Glo Assay (Promega), measuring the monoamine oxidase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
US Patent